Detalhe da pesquisa
1.
Adjuvant Gemcitabine Versus Neoadjuvant/Adjuvant FOLFIRINOX in Resectable Pancreatic Cancer: The Randomized Multicenter Phase II NEPAFOX Trial.
Ann Surg Oncol
; 31(6): 4073-4083, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38459418
2.
Onset Time and Characteristics of Postprocedural Bleeding after Endoscopic Resection of Colorectal Lesions: A Multicenter Retrospective Study.
Dig Dis
; 42(1): 78-86, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-37812925
3.
Perioperative FLOT plus ramucirumab for resectable esophagogastric adenocarcinoma: A randomized phase II/III trial of the German AIO and Italian GOIM.
Int J Cancer
; 153(1): 153-163, 2023 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36883420
4.
Pazopanib with 5-FU and oxaliplatin as first line therapy in advanced gastric cancer: A randomized phase-II study-The PaFLO trial. A study of the Arbeitsgemeinschaft Internistische Onkologie AIO-STO-0510.
Int J Cancer
; 150(6): 1007-1017, 2022 03 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34741530
5.
Trastuzumab in combination with 5-fluorouracil, leucovorin, oxaliplatin and docetaxel as perioperative treatment for patients with human epidermal growth factor receptor 2-positive locally advanced esophagogastric adenocarcinoma: A phase II trial of the Arbeitsgemeinschaft Internistische Onkologie Gastric Cancer Study Group.
Int J Cancer
; 149(6): 1322-1331, 2021 09 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34019698
6.
Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry.
Int J Cancer
; 148(6): 1478-1488, 2021 03 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33038277
7.
Phase III randomized, double-blind study of paclitaxel with and without everolimus in patients with advanced gastric or esophagogastric junction carcinoma who have progressed after therapy with a fluoropyrimidine/platinum-containing regimen (RADPAC).
Int J Cancer
; 147(9): 2493-2502, 2020 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32339253
8.
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial.
Lancet
; 393(10184): 1948-1957, 2019 05 11.
Artigo
Inglês
| MEDLINE | ID: mdl-30982686
9.
Radiochemotherapy with or without cetuximab for unresectable esophageal cancer: final results of a randomized phase 2 trial (LEOPARD-2).
Strahlenther Onkol
; 196(9): 795-804, 2020 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-32533228
10.
ASO Visual Abstract: Adjuvant Gemcitabine Versus Neoadjuvant/Adjuvant FOLFIRINOX in Resectable Pancreatic Cancer-The Randomized Multicenter Phase II NEPAFOX Trial.
Ann Surg Oncol
; 31(6): 4121-4122, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38575722
11.
The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase III trial of the German AIO/CAO-V/CAOGI.
BMC Cancer
; 17(1): 893, 2017 12 28.
Artigo
Inglês
| MEDLINE | ID: mdl-29282088
12.
Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial.
Lancet Oncol
; 17(12): 1697-1708, 2016 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-27776843
13.
VEGFR-3 and CXCR4 as predictive markers for treatment with fluorouracil, leucovorin plus either oxaliplatin or cisplatin in patients with advanced esophagogastric cancer: a comparative study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).
BMC Cancer
; 14: 476, 2014 Jul 01.
Artigo
Inglês
| MEDLINE | ID: mdl-24981311
14.
Quality of life of older adult patients receiving docetaxel-based chemotherapy triplets for esophagogastric adenocarcinoma: a randomized study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).
Gastric Cancer
; 17(1): 181-7, 2014 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-23455717
15.
Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial.
J Clin Oncol
; 42(4): 410-420, 2024 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37963317
16.
Pembrolizumab and trastuzumab in combination with FLOT in the perioperative treatment of HER2-positive, localized esophagogastric adenocarcinoma-a phase II trial of the AIO study group (AIO STO 0321).
Front Oncol
; 13: 1272175, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37909020
17.
Pathological complete remission in patients with oesophagogastric cancer receiving preoperative 5-fluorouracil, oxaliplatin and docetaxel.
Int J Cancer
; 130(7): 1706-13, 2012 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-21618509
18.
FLOT Versus FLOT/Trastuzumab/Pertuzumab Perioperative Therapy of Human Epidermal Growth Factor Receptor 2-Positive Resectable Esophagogastric Adenocarcinoma: A Randomized Phase II Trial of the AIO EGA Study Group.
J Clin Oncol
; 40(32): 3750-3761, 2022 11 10.
Artigo
Inglês
| MEDLINE | ID: mdl-35709415
19.
Ethanol-mediated carcinogenesis in the human esophagus implicates CYP2E1 induction and the generation of carcinogenic DNA-lesions.
Int J Cancer
; 128(3): 533-40, 2011 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-20715111
20.
Local calprotectin production in colorectal cancer and polyps--active neutrophil recruitment in carcinogenesis.
Int J Colorectal Dis
; 26(5): 603-7, 2011 May.
Artigo
Inglês
| MEDLINE | ID: mdl-21380506